-
1
-
-
84912016691
-
The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection
-
Sun X, Hirota SA. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol Immunol. 2015;63:193-202.
-
(2015)
Mol Immunol.
, vol.63
, pp. 193-202
-
-
Sun, X.1
Hirota, S.A.2
-
2
-
-
80053253206
-
Biology of Clostridium difficile : Implications for epidemiology and diagnosis
-
Carroll KC, Bartlett JG. Biology of Clostridium difficile : implications for epidemiology and diagnosis. Annu Rev Microbiol. 2011;65:501-521.
-
(2011)
Annu Rev Microbiol.
, vol.65
, pp. 501-521
-
-
Carroll, K.C.1
Bartlett, J.G.2
-
3
-
-
0036467063
-
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
-
Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346-353.
-
(2002)
Clin Infect Dis.
, vol.34
, pp. 346-353
-
-
Kyne, L.1
Hamel, M.B.2
Polavaram, R.3
Kelly, C.P.4
-
4
-
-
35348962496
-
The emerging infectious challenge of Clostridium difficile -associated disease in Massachusetts hospitals: Clinical and economic consequences
-
O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile -associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219-1227.
-
(2007)
Infect Control Hosp Epidemiol.
, vol.28
, pp. 1219-1227
-
-
O’Brien, J.A.1
Lahue, B.J.2
Caro, J.J.3
Davidson, D.M.4
-
5
-
-
0030726256
-
Clostridium difficile -associated diarrhea in HIV-infected patients: Epidemiology and risk factors
-
Barbut F, Meynard JL, Guiguet M, et al. Clostridium difficile -associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:176-181.
-
(1997)
J Acquir Immune Defic Syndr Hum Retrovirol.
, vol.16
, pp. 176-181
-
-
Barbut, F.1
Meynard, J.L.2
Guiguet, M.3
-
6
-
-
0035436311
-
Epidemiology of Clostridium difficile -associated infections
-
Barbut F, Petit JC. Epidemiology of Clostridium difficile -associated infections. Clin Microbiol Infect. 2001;7:405-410.
-
(2001)
Clin Microbiol Infect.
, vol.7
, pp. 405-410
-
-
Barbut, F.1
Petit, J.C.2
-
7
-
-
0025440048
-
Risk factors for Clostridium difficile toxin-associated diarrhea
-
Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990;11:283-290.
-
(1990)
Infect Control Hosp Epidemiol.
, vol.11
, pp. 283-290
-
-
Brown, E.1
Talbot, G.H.2
Axelrod, P.3
Provencher, M.4
Hoegg, C.5
-
8
-
-
0027423999
-
Risk factors for Clostridium difficile -associated diarrhoea in HIV-infected patients
-
Hutin Y, Molina JM, Casin I, et al. Risk factors for Clostridium difficile -associated diarrhoea in HIV-infected patients. AIDS. 1993;7: 1441-1447.
-
(1993)
AIDS.
, vol.7
, pp. 1441-1447
-
-
Hutin, Y.1
Molina, J.M.2
Casin, I.3
-
9
-
-
80455173556
-
Host and pathogen factors for Clostridium difficile infection and colonization
-
Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693-1703.
-
(2011)
N Engl J Med.
, vol.365
, pp. 1693-1703
-
-
Loo, V.G.1
Bourgault, A.M.2
Poirier, L.3
-
10
-
-
84896454372
-
Medication risk factors associated with healthcare-associated Clostridium difficile infection: A multilevel model case-control study among 64 US academic medical centres
-
Pakyz AL, Jawahar R, Wang Q, Harpe SE. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother. 2014;69:1127-1131.
-
(2014)
J Antimicrob Chemother.
, vol.69
, pp. 1127-1131
-
-
Pakyz, A.L.1
Jawahar, R.2
Wang, Q.3
Harpe, S.E.4
-
11
-
-
84876236060
-
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection
-
Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57:2326-2332.
-
(2013)
Antimicrob Agents Chemother.
, vol.57
, pp. 2326-2332
-
-
Brown, K.A.1
Khanafer, N.2
Daneman, N.3
Fisman, D.N.4
-
12
-
-
0034452451
-
Environmental control to reduce transmission of Clostridium difficile
-
Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31: 995-1000.
-
(2000)
Clin Infect Dis.
, vol.31
, pp. 995-1000
-
-
Mayfield, J.L.1
Leet, T.2
Miller, J.3
Mundy, L.M.4
-
13
-
-
84867484375
-
Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections
-
Rupp ME, Cavalieri RJ, Lyden E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol. 2012;33:1094-1100.
-
(2012)
Infect Control Hosp Epidemiol.
, vol.33
, pp. 1094-1100
-
-
Rupp, M.E.1
Cavalieri, R.J.2
Lyden, E.3
-
15
-
-
84862293439
-
World Gastroenterology Organisation Global Guidelines: Probiotics and prebiotics October 2011
-
Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46:468-481.
-
(2012)
J Clin Gastroenterol.
, vol.46
, pp. 468-481
-
-
Guarner, F.1
Khan, A.G.2
Garisch, J.3
-
16
-
-
84860708876
-
Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis
-
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959-1969.
-
(2012)
JAMA.
, vol.307
, pp. 1959-1969
-
-
Hempel, S.1
Newberry, S.J.2
Maher, A.R.3
-
17
-
-
84871349683
-
Probiotics for the prevention of Clostridium difficile -associated diarrhea: A systematic review and meta-analysis
-
Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile -associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157:878-888.
-
(2012)
Ann Intern Med.
, vol.157
, pp. 878-888
-
-
Johnston, B.C.1
Ma, S.S.2
Goldenberg, J.Z.3
-
18
-
-
85038444044
-
Probiotics for the prevention of Clostridium difficile -associated diarrhea in adults and children
-
Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile -associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.
-
(2013)
Cochrane Database Syst Rev.
, vol.5
-
-
Goldenberg, J.Z.1
Ma, S.S.2
Saxton, J.D.3
-
19
-
-
84889608780
-
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: A multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)
-
Allen SJ, Wareham K, Wang D, et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess. 2013;17:1-140.
-
(2013)
Health Technol Assess.
, vol.17
, pp. 1-140
-
-
Allen, S.J.1
Wareham, K.2
Wang, D.3
-
20
-
-
84891614402
-
Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections
-
Shan LS, Hou P, Wang ZJ, et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes. 2013;4:329-334.
-
(2013)
Benef Microbes.
, vol.4
, pp. 329-334
-
-
Shan, L.S.1
Hou, P.2
Wang, Z.J.3
-
21
-
-
84894186045
-
A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: A randomised controlled trial
-
Wong S, Jamous A, O'Driscoll J, et al. A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. Br J Nutr. 2014;111:672-678.
-
(2014)
Br J Nutr.
, vol.111
, pp. 672-678
-
-
Wong, S.1
Jamous, A.2
O’Driscoll, J.3
-
22
-
-
84891625369
-
Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
-
Ouwehand AC, DongLian C, Weijian X, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine. 2014;32:458-463.
-
(2014)
Vaccine.
, vol.32
, pp. 458-463
-
-
Ouwehand, A.C.1
DongLian, C.2
Weijian, X.3
-
23
-
-
0000795948
-
Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis
-
Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49:390-402.
-
(1935)
Am J Dis Child.
, vol.49
, pp. 390-402
-
-
Hall, I.C.1
O'Toole, E.2
-
25
-
-
67649391053
-
Clostridium difficile infection: New developments in epidemiology and pathogenesis
-
Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:526-536.
-
(2009)
Nat Rev Microbiol.
, vol.7
, pp. 526-536
-
-
Rupnik, M.1
Wilcox, M.H.2
Gerding, D.N.3
-
26
-
-
84912046394
-
Clostridium difficile infection: Update on diagnosis, epidemiology, and treatment strategies
-
To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. Surg Infect (Larchmt). 2014;15:490-502.
-
(2014)
Surg Infect (Larchmt).
, vol.15
, pp. 490-502
-
-
To, K.B.1
Napolitano, L.M.2
-
27
-
-
84908178824
-
The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010
-
Reveles KR, Lee GC, Boyd NK, Frei CR. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am J Infect Control. 2014;42:1028-1032.
-
(2014)
Am J Infect Control.
, vol.42
, pp. 1028-1032
-
-
Reveles, K.R.1
Lee, G.C.2
Boyd, N.K.3
Frei, C.R.4
-
28
-
-
77951026738
-
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
-
Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
-
(2010)
Infect Control Hosp Epidemiol.
, vol.31
, pp. 431-455
-
-
Cohen, S.H.1
Gerding, D.N.2
Johnson, S.3
-
29
-
-
25144469664
-
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
-
Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079-1084.
-
(2005)
Lancet.
, vol.366
, pp. 1079-1084
-
-
Warny, M.1
Pepin, J.2
Fang, A.3
-
30
-
-
84871990888
-
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
-
He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45:109-113.
-
(2013)
Nat Genet.
, vol.45
, pp. 109-113
-
-
He, M.1
Miyajima, F.2
Roberts, P.3
-
31
-
-
84870168265
-
Preventing Clostridium difficile infection in the intensive care unit
-
Zilberberg MD, Shorr AF. Preventing Clostridium difficile infection in the intensive care unit. Crit Care Clin. 2013;29:11-18.
-
(2013)
Crit Care Clin.
, vol.29
, pp. 11-18
-
-
Zilberberg, M.D.1
Shorr, A.F.2
-
32
-
-
77957376775
-
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production
-
Merrigan M, Venugopal A, Mallozzi M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192:4904-4911.
-
(2010)
J Bacteriol.
, vol.192
, pp. 4904-4911
-
-
Merrigan, M.1
Venugopal, A.2
Mallozzi, M.3
-
33
-
-
84922032670
-
The potential for emerging therapeutic options for Clostridium difficile infection
-
Mathur H, Rea MC, Cotter PD, Ross RP, Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes. 2014;5:696-710.
-
(2014)
Gut Microbes.
, vol.5
, pp. 696-710
-
-
Mathur, H.1
Rea, M.C.2
Cotter, P.D.3
Ross, R.P.4
Hill, C.5
-
34
-
-
84926417736
-
Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs vancomycin for the treatment of recurrent Clostridium difficile infection
-
Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41:835-843.
-
(2015)
Aliment Pharmacol Ther.
, vol.41
, pp. 835-843
-
-
Cammarota, G.1
Masucci, L.2
Ianiro, G.3
-
35
-
-
84947125813
-
Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead
-
Borody T, Fischer M, Mitchell S, Campbell J. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead. Expert Rev Gastroenterol Hepatol. 2015;9(11):1379-1391.
-
(2015)
Expert Rev Gastroenterol Hepatol
, vol.9
, Issue.11
, pp. 1379-1391
-
-
Borody, T.1
Fischer, M.2
Mitchell, S.3
Campbell, J.4
-
36
-
-
84900418033
-
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study
-
Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58:1515-1522.
-
(2014)
Clin Infect Dis.
, vol.58
, pp. 1515-1522
-
-
Youngster, I.1
Sauk, J.2
Pindar, C.3
-
37
-
-
58849144336
-
The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile -associated diarrhea
-
Rohde CL, Bartolini V, Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile -associated diarrhea. Nutr Clin Pract. 2009;24:33-40.
-
(2009)
Nutr Clin Pract.
, vol.24
, pp. 33-40
-
-
Rohde, C.L.1
Bartolini, V.2
Jones, N.3
-
38
-
-
62149117549
-
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors
-
Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009;9:35.
-
(2009)
BMC Microbiol.
, vol.9
, pp. 35
-
-
Jones, S.E.1
Versalovic, J.2
-
39
-
-
84924921458
-
Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis
-
Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547-1561.
-
(2014)
Am J Gastroenterol.
, vol.109
, pp. 1547-1561
-
-
Ford, A.C.1
Quigley, E.M.2
Lacy, B.E.3
-
40
-
-
84893687483
-
Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: Meta-analysis of randomized controlled trials
-
Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20:21-35.
-
(2014)
Inflamm Bowel Dis.
, vol.20
, pp. 21-35
-
-
Shen, J.1
Zuo, Z.X.2
Mao, A.P.3
-
41
-
-
84855826006
-
A meta-analysis and systematic review on the effect of probiotics in acute diarrhea
-
Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets. 2012;11:3-14.
-
(2012)
Inflamm Allergy Drug Targets.
, vol.11
, pp. 3-14
-
-
Salari, P.1
Nikfar, S.2
Abdollahi, M.3
-
42
-
-
29244491643
-
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
-
Duman DG, Bor S, Ozutemiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol. 2005;17:1357-1361.
-
(2005)
Eur J Gastroenterol Hepatol.
, vol.17
, pp. 1357-1361
-
-
Duman, D.G.1
Bor, S.2
Ozutemiz, O.3
-
44
-
-
0034839847
-
Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial
-
Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 2001;76: 883-889.
-
(2001)
Mayo Clin Proc.
, vol.76
, pp. 883-889
-
-
Thomas, M.R.1
Litin, S.C.2
Osmon, D.R.3
Corr, A.P.4
Weaver, A.L.5
Lohse, C.M.6
-
45
-
-
38649108836
-
Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial
-
Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007;21:732-736.
-
(2007)
Can J Gastroenterol.
, vol.21
, pp. 732-736
-
-
Beausoleil, M.1
Fortier, N.2
Guenette, S.3
-
46
-
-
34547569295
-
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylor i therapy: A prospective randomized placebo-controlled double-blind study
-
Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylor i therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter. 2007;12:309-316.
-
(2007)
Helicobacter.
, vol.12
, pp. 309-316
-
-
Cindoruk, M.1
Erkan, G.2
Karakan, T.3
Dursun, A.4
Unal, S.5
-
47
-
-
75749114116
-
Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics
-
Lonnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44:106-112.
-
(2010)
J Clin Gastroenterol.
, vol.44
, pp. 106-112
-
-
Lonnermark, E.1
Friman, V.2
Lappas, G.3
Sandberg, T.4
Berggren, A.5
Adlerberth, I.6
-
48
-
-
0028985777
-
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
-
McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995;90:439-448.
-
(1995)
Am J Gastroenterol.
, vol.90
, pp. 439-448
-
-
McFarland, L.V.1
Surawicz, C.M.2
Greenberg, R.N.3
-
49
-
-
0024562960
-
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
-
Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van BG. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989;96:981-988.
-
(1989)
Gastroenterology.
, vol.96
, pp. 981-988
-
-
Surawicz, C.M.1
Elmer, G.W.2
Speelman, P.3
McFarland, L.V.4
Chinn, J.5
van, B.G.6
-
50
-
-
0033229628
-
Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study
-
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
-
(1999)
Pediatrics.
, vol.104
-
-
Arvola, T.1
Laiho, K.2
Torkkeli, S.3
-
51
-
-
2942704185
-
Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C. Difficile diarrhoea
-
Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7:59-62.
-
(2004)
Int Microbiol.
, vol.7
, pp. 59-62
-
-
Plummer, S.1
Weaver, M.A.2
Harris, J.C.3
Dee, P.4
Hunter, J.5
-
52
-
-
15044347921
-
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: A randomized double-blind placebo-controlled trial
-
Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21:583-590.
-
(2005)
Aliment Pharmacol Ther.
, vol.21
, pp. 583-590
-
-
Kotowska, M.1
Albrecht, P.2
Szajewska, H.3
-
53
-
-
33645544410
-
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: A prospective study
-
Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006;12:I19-I22.
-
(2006)
Med Sci Monit.
, vol.12
, pp. I19-I22
-
-
Can, M.1
Besirbellioglu, B.A.2
Avci, I.Y.3
Beker, C.M.4
Pahsa, A.5
-
54
-
-
34447630803
-
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial
-
Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.
-
(2007)
BMJ.
, vol.335
, pp. 80
-
-
Hickson, M.1
D'Souza, A.L.2
Muthu, N.3
-
55
-
-
58849147241
-
Prevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [abstract]
-
Rafiq R, Pandey D, Osman SM, Masood R, Donepudi I, Norkus E. Prevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [abstract]. Gastroenterology. 2007;132(Suppl 2):A187.
-
(2007)
Gastroenterology
, vol.132
-
-
Rafiq, R.1
Pandey, D.2
Osman, S.M.3
Masood, R.4
Donepudi, I.5
Norkus, E.6
-
57
-
-
44649140406
-
Clinical trial: Effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children
-
Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther. 2008;28:154-161.
-
(2008)
Aliment Pharmacol Ther.
, vol.28
, pp. 154-161
-
-
Ruszczynski, M.1
Radzikowski, A.2
Szajewska, H.3
-
58
-
-
55949121333
-
Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans
-
Safdar N, Barigala R, Said A, McKinley L. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. J Clin Pharm Ther. 2008;33:663-668.
-
(2008)
J Clin Pharm Ther.
, vol.33
, pp. 663-668
-
-
Safdar, N.1
Barigala, R.2
Said, A.3
McKinley, L.4
-
59
-
-
39049109557
-
Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink
-
Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr. 2008;62:299-301.
-
(2008)
Eur J Clin Nutr.
, vol.62
, pp. 299-301
-
-
Wenus, C.1
Goll, R.2
Loken, E.B.3
Biong, A.S.4
Halvorsen, D.S.5
Florholmen, J.6
-
60
-
-
77954424086
-
Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients
-
Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105:1636-1641.
-
(2010)
Am J Gastroenterol.
, vol.105
, pp. 1636-1641
-
-
Gao, X.W.1
Mubasher, M.2
Fang, C.Y.3
Reifer, C.4
Miller, L.E.5
-
61
-
-
77949370649
-
Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study
-
Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study. Arch Med Sci. 2010;6:56-64.
-
(2010)
Arch Med Sci.
, vol.6
, pp. 56-64
-
-
Sampalis, J.1
Psaradellis, E.2
Rampakakis, E.3
-
62
-
-
84861908072
-
Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: A single-center, randomized, double-blind, placebo-controlled trial
-
Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2012;107:922-931.
-
(2012)
Am J Gastroenterol.
, vol.107
, pp. 922-931
-
-
Pozzoni, P.1
Riva, A.2
Bellatorre, A.G.3
-
63
-
-
84878143512
-
Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial
-
Selinger CP, Bell A, Cairns A, Lockett M, Sebastian S, Haslam N. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J Hosp Infect. 2013;84:159-165.
-
(2013)
J Hosp Infect.
, vol.84
, pp. 159-165
-
-
Selinger, C.P.1
Bell, A.2
Cairns, A.3
Lockett, M.4
Sebastian, S.5
Haslam, N.6
|